1. Home
  2. SKIL vs ELOX Comparison

SKIL vs ELOX Comparison

Compare SKIL & ELOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Skillsoft Corp.

SKIL

Skillsoft Corp.

HOLD

Current Price

$6.57

Market Cap

40.2M

Sector

Technology

ML Signal

HOLD

Logo Eloxx Pharmaceuticals Inc. Common Stock

ELOX

Eloxx Pharmaceuticals Inc. Common Stock

N/A

Current Price

$12.11

Market Cap

41.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
SKIL
ELOX
Founded
1998
N/A
Country
United States
United States
Employees
2247
7
Industry
Computer Software: Prepackaged Software
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
40.2M
41.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SKIL
ELOX
Price
$6.57
$12.11
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
114.4K
55.8K
Earning Date
04-07-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$0.11
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.43
$10.00
52 Week High
$18.45
$15.00

Technical Indicators

Market Signals
Indicator
SKIL
ELOX
Relative Strength Index (RSI) 50.79 40.75
Support Level $6.30 $10.51
Resistance Level $8.11 $14.37
Average True Range (ATR) 0.53 1.67
MACD -0.04 0.05
Stochastic Oscillator 30.59 23.02

Price Performance

Historical Comparison
SKIL
ELOX

About SKIL Skillsoft Corp.

Skillsoft Corp is a leader in corporate digital learning. The company's segments include Talent Development Solutions and Global Knowledge. Talent Development Solutions brings a foundation of products and customers. TDS enterprise-grade solution serves customers and employees world-wide. TDS Learner is a world-renowned consumer-scale and experiential learning platform that serves learners internationally. The Global Knowledge segment is centered around instructor-led training, or live learning, with face-to-face delivery by experienced trainers, both in-person and virtually.

About ELOX Eloxx Pharmaceuticals Inc. Common Stock

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.

Share on Social Networks: